X-Therma Inc. received 2nd place for the 2018 International Marine Innovation and Entrepreneurship Competition in Qingdao, China for XT-ViVo, the ocean-inspired nanoscience breakthrough to revolutionize the cold chain of regenerative medicine.
Meet us at China-US Entrepreneur & Investment Summit Tomorrow (July 21st at Santa Clara Convention Center). Dr. Mark Kline (CTO of X-Therma) will reveal how X-Therma technology will revolutionize Human Organ Transplants and save millions of lives! https://www.eventbrite.com/e/china-us-venture-investment-summit-tickets-47439030417 China-US Venture & Investment Summit – eventbrite.com www.eventbrite.com Eventbrite – Silicon Valley Technology Innovation and […]
X-Therma CTO Dr. Mark Kline will give an insightful presentation at University of California, Berkeley (UCB) Stem Cell Retreat in Monterey, CA where the frontier stem cell research of UC-Berkeley and others is revealed annually. We are here to help scientists with better solutions to preserve the precious stem cells and engineered organs.
X-Therma was awarded 3rd place (241 teams in Silicon Valley, 1400 teams globally) of “The 2nd China Shenzhen Innovation and Entrepreneurship International Competition”, Silicon Valley division and brought home a prize of RMB 30,000. Congratulations to the Team!
X-Therma CEO Dr. Xiaoxi Wei welcomed her first baby into the world and is proud he became the first donor and “Patient” for X-Therma CORDX program. The medical team at Kaiser Permanente Oakland Medical Center collected the cord blood, cord tissue and placenta from the newborn with X-Therma’s collection kit. The precious cord and placental […]
Dr. Mark Kline, Chief Technology Officer of X-Therma will deliver an enchanting entreprenuer story at the American Chemical Society (ACS) Entreprenuer Summit on Nov 15-16th, Washington D.C. https://www.acs.org/content/acs/en/meetings/acs-entrepreneur-summit.html
X-Therma CEO Dr. Xiaoxi Wei is invited to give a plenary talk and a section presentation on our new generation of cryoprotectants for the regenerative medicine industry at the CRYO17 Meeting in Hefei, China
X-Therma is selected by the California Institute of Regenerative Medicine (CIRM) for highly competitive funding to fuel X-Therma’s development to advance critical stem cell manufacturing processes.
X-Therma is competitively selected for a third US Department of the Army SBIR Phase II SBIR contract. X-Therma’s CryomatrixTM is a new pipeline of non-toxic and hyper-effective cryoprotectants in development for cell, tissue, and organ banking.